Menu UF Health Home Menu
 

Agenda

Thursday, February 9, 2017

07:30 a.m. – 05:00 p.m.
Symposium Registration
 

08:00 a.m. – 05:00 p.m.
Pre-Symposium Workshops:
 

Pre-Symposium Workshop #1: 09:00 a.m. – 04:55 p.m.: Advances in Breast Surgery and Reconstruction – An Interactive Course
Charles E. Cox, MD, Risal Djohan, MD, Stephen R. Grobmyer, MD, Suzanne Klimberg, MD, Michael Sabel, MD, and David Weintritt, MD
 

Pre-Symposium Workshop #2: 08:00 a.m. – 05:00 p.m.: Tomosynthesis
Gary M. Levine, MD, Constance D. Lehman, MD, PhD, and Martha Wasserman, MD
 

Pre-Symposium Workshop #3: 09:00 a.m. – 04:00 p.m.: Difficult to Diagnose Cases in Breast Pathology
Edi Brogi, MD, Shahla Masood, MD, Jorge Reis-Filho, MD, PhD
 

Pre-Symposium Workshop #4: 01:00 p.m. – 04:00 p.m.: Breast Cancer Risk and Genetic Testing in the Modern Era
Banu Arun, MD, Claudine Isaacs, MD, Shahla Masood, MD, Freya Schnabel, MD, and Marie Wood, MD
 

Friday, February 10, 2017

07:00 a.m. – 08:00 a.m.
Registration, Breakfast and Exhibits
 

08:00 a.m. – 08:10 a.m.
Introductory Remarks – Shahla Masood, MD
 

08:10 a.m. – 08:15 a.m.
Introduction of Keynote Speaker – Armando E. Giuliano, MD
 

08:15 a.m. – 09:00 a.m.
Keynote Lecture – Why Don’t We Get More Cancer? The Critical Role of Extracellular Matrix and Microenvironment in Metastasis and Dormancy – Mina J. Bissell, PhD
 

Session I  – New Trends in Breast Cancer Diagnosis and Therapy

Moderators
Armando E. Giuliano, MD
 

09:00 a.m. – 09:30 a.m.
Breast Imaging and Over Diagnosis of Breast Cancer: Part of the Solution or the Problem? – Constance D. Lehman, MD, PhD
 

09:30 a.m. – 10:00 a.m.
“Borderline Breast Disease”: An Entity to Minimize Errors in Over Diagnosis of Low Grade Ductal Carcinoma in Situ in Breast Pathology – Shahla Masood, MD
 

10:00 a.m. – 10:30 a.m.
BREAK, EXHIBITS, AND POSTER SESSION
 

10:30 a.m. – 11:00 a.m.
Are We Over-Treating Ductal Carcinoma in Situ: To Excise or Not to Excise – Melvin J. Silverstein, MD
 

11:00 a.m. – 11:30 a.m.
 Is There Value to Genomic Analysis of Ductal Carcinoma in Situ? Is Radiation Always Necessary? – Lawrence Solin, MD
 

11:30 a.m. – 12:00 p.m.
 Chemoprevention for Ductal Carcinoma in Situ: Is it Ready for Primetime? – Adam Brufsky, MD, PhD
 

12:00 p.m. – 12:30 p.m.
PANEL DISCUSSION
 

12:30 p.m. – 01:30 p.m.
LUNCH, EXHIBITS, AND POSTER SESSION
 


Session II – New Advances in Breast Cancer Diagnosis and Therapy 

Moderators
Lawrence Solin, MD
 

01:30 p.m. – 02:00 p.m.
Imaging Patients With Dense Breast? – Constance D. Lehman, MD, PhD
 

02:00 p.m. – 02:30 p.m.
Tomosynthesis Update– Gary M. Levine, MD
 

02:30 p.m. – 03:00 p.m.
Toward a Rational Approach to Breast MRI – Constance D. Lehman, MD, PhD
 

03:00 p.m. – 03:30 p.m.
BREAK, EXHIBITS AND POSTER SESSION
 

03:30 p.m. – 04:00 p.m.
Management of Benign and Atypical Lesions Diagnosed at Needle Core Biopsy: What to Excise and When – Edi Brogi, MD, PhD
 

04:00 p.m. – 04:30 p.m.
Is There a Practical Value to Whole Gene Sequencing for Molecular Characterization of Breast Cancer? – Jorge Reis-Filho, MD, PhD
 

04:30 p.m. – 05:00 p.m.
PANEL DISCUSSION
 

 

 

Saturday, February 11, 2017

07:00 a.m. – 08:00 a.m.
Registration, Breakfast and Exhibits
 


Session III – Current Trends in Surgical Management of Breast Cancer

Moderators
Stephen R. Grobmyer, MD
 

08:00 a.m. – 08:30 a.m.
Lumpectomy and Margin Assessment: State of the Art for 2017 – Armando E. Giuliano, MD
 

08:30 a.m. – 09:00 a.m.
Nipple Sparing Mastectomy: Is it Really Safe? – Suzanne Klimberg, MD
 

09:00 a.m. – 09:30 a.m.
Intraoperative Radiation Therapy: An Update – Stephen R. Grobmyer, MD
 

09:30 a.m. – 10:00 a.m.
 
BREAK, EXHIBITS AND POSTER SESSION
 

10:00 a.m. – 10:30 a.m.
Managing Expectation in Breast Reconstruction: Balancing Complexity of Reconstruction with Patient Satisfaction and Outcome – Risal Djohan, MD
 

10:30 a.m. – 11:00 a.m.
Management of the Patient With a Positive SN: Update on ACOSOG Z0011 – Armando E. Giuliano, MD
 

11:00 a.m. – 11:30 a.m.
Surgical Intervention in High Risk Individuals – Michael Sabel, MD
 

11:30 a.m. – 12:00 p.m.
PANEL DISCUSSION
 

12:00 p.m. – 01:30 p.m.
LUNCH, EXHIBITS, POSTER SESSION & THE BREAST JOURNAL AWARDS
 

Session IV  – Innovation in Breast Cancer Therapy

Moderators
D. Scott Lind, MD
 

01:30 p.m. – 02:00 p.m.
Prognostic and Predictive Factors – Jorge Reis-Filho, MD, PhD
 

02:00 p.m. – 02:30 p.m.
Immunotherapy Update on Breast Cancer – Marie Wood, MD
 

02:30 p.m. – 03:00 p.m.
Neoadjuvant Chemotherapy: Patient Selection and Current Regimens – Hyman Muss, MD
 

03:00 p.m. – 03:30 p.m.
BREAK, EXHIBITS AND POSTER SESSION
 

03:30 p.m. – 04:00 p.m.
 
Controversies in Radiotherapy for Breast Cancer – Julie Bradley, MD
 

04:00 p.m. – 04:30 p.m.
 
Management of HER-2/Positive and Triple Negative Breast Cancer – Joyce O’Shaughnessy, MD
 

04:30 p.m. – 05:00 p.m.
 
Multidisciplinary Tumor Conference – Melvin J. Silverstein, MD
 

05:00 p.m. – 05:30 p.m.
 
PANEL DISCUSSION
 

 

Sunday, February 12, 2017

07:00 a.m. – 08:00 a.m.
Registration and Breakfast
 


Session V – Contemporary Issues in Breast Cancer

Moderators
Terry Mamounas, MD
 

08:00 a.m. – 08:30 a.m.
New Developments in Duration of Adjuvant Hormonal Therapy – Terry Mamounas, MD
 

08:30 a.m. – 09:00 a.m.
Inherited Cancer Syndromes – Heather Macdonald, MD
 

09:00 a.m. – 09:30 a.m.
Breast Cancer in the Elderly – Hyman Muss, MD
 

09:30 a.m. – 10:00 a.m.
Management of Symptoms During and After Breast Cancer Therapy – Oxana Palesh, PhD, MPH
 

10:00 a.m. – 10:30 a.m.
Pregnancy Associated Breast Cancer Fertility Prevention – Heather Macdonald, MD
 

10:30 a.m. – 11:00 a.m.
Closing Remarks – Judith A. Salerno, MD, MS
 

11:00 a.m. – 11:30 a.m.
PANEL DISCUSSION & ADJOURN
 

 

Tagged as: ,